MONICA MOORE: Open Payments
NPI 1871810812 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 71 payments from 12 companies in 2025. Trend: 2023 $381 · 2024 $1,374 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $625 |
| Madrigal Pharmaceuticals | 8 | $378 |
| Ardelyx, Inc. | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
| Gilead Sciences, Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $34 |
| Novo Nordisk Inc | 2 | $33 |
| EVOKE PHARMA, INC. | 1 | $17 |
Products named: REZDIFFRA, LINZESS, RINVOQ, SKYRIZI, CREON, IBSRELA, ENTYVIO, TREMFYA.
Industry payments across AL — which companies pay providers there.
